Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial.

Philip D J DunneDavid YoungCher Shiong ChuahPeter C HayesDhiraj TripathiJoanna LeitheadLyn A SmithDaniel R GayaEwan H ForrestAdrian J Stanley

Published in: Alimentary pharmacology & therapeutics (2022)

Following OVB in cirrhotic patients, carvedilol use is associated with survival benefit, fewer liver-related deaths and fewer hospital admissions with decompensated liver disease. Further studies are needed to validate this finding.

Keyphrases

ejection fraction
end stage renal disease
clinical trial
heart failure
newly diagnosed
prognostic factors
open label
ultrasound guided
study protocol
patient reported outcomes
hepatitis b virus